A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med 2018;198:1151–1164.

The Zephyr Valve procedure is a minimally invasive treatment for severe or very severe COPD and emphysema. It offers an alternative to highly invasive options like lung transplants, which carry ...

The Zephyr Valve is a minimally invasive treatment requiring no incisions or cutting. The one-time procedure is done during a simple 30-60 minute bronchoscopy that requires no incision.

The Zephyr Valve treatment is a less invasive treatment option for severe emphysema (COPD) that has been shown to deliver life-changing benefits to patients without the risk of major surgery.

The Zephyr Valve is a minimally invasive treatment option for severe emphysema, a form of COPD. Placed via bronchoscopy, the valves block off a diseased portion of the lung, allowing the healthier ...

The Zephyr Valve is commercially available in more than 25 countries, with over 80,000 valves used to treat more than 20,000 patients. For more information on the Zephyr Valves, please visit www ...

The Zephyr Valve is a minimally invasive treatment option that can deliver significant benefits to patients including improvements in lung function, exercise capacity, and quality of life.1 Placed ...

The Zephyr Valve procedure is a minimally invasive treatment for severe or very severe COPD and emphysema. It offers an alternative to highly invasive options like lung transplants, which carry ...

The Zephyr Valve is now commercially available in more than 25 countries, with over 76,000 valves used to treat more than 19,000 patients. For more information, visit www.MyLungsMyLife.com.

The Zephyr valve is the first minimally invasive device approved in the United States for the treatment of patients with severe emphysema, the company noted in a news release.

The results for the primary endpoint were previously reported.ii The long-term data show that in patients with severe heterogeneous emphysema, Zephyr Valve treatment provided a durable reduction ...

The results for the primary endpoint were previously reported. ii The long-term data show that in patients with severe heterogeneous emphysema, Zephyr Valve treatment provided a durable reduction ...